ABSTRACT
A Korean isolate of the sacbrood virus infecting Apis cerana (AcSBV-Kor) is the most destructive honeybee virus, causing serious economic damage losses in Korean apiculture. To address this, here, we attempted to develop an assay for the rapid detection of AcSBV-Kor based on immunochromatographic detection of constituent viral proteins. Genes encoding VP1 and VP2 proteins of AcSBV-Kor were cloned into an expression vector (pET-28a) and expressed in Escherichia coli BL21(DE3). During purification, recombinant VP1 (rVP1) and VP2 (rVP2) proteins were found in the insoluble fraction, with a molecular size of 26.7 and 24.9 kDa, respectively. BALB/c mice immunized with the purified rVP1 and rVP2 produced polyclonal antibodies (pAbs) such as pAb-rVP1 and pAb-rVP2. Western blot analysis showed that pAb-rVP1 strongly reacted with the homologous rVP1 but weakly reacted with heterologous rVP2. However, pAb-rVP2 strongly reacted not only with the homologous rVP2 but also with the heterologous rVP1. Spleen cells of the immunized mice fused with SP2/0-Ag14 myeloma cells produced monoclonal antibodies (mAbs) such as mAb-rVP1-1 and mAb-rVP2-13. Western blot analysis indicated that pAb-rVP1, pAb-rVP2, mAb-rVP1-1, and mAb-rVP2-13 reacted with AcSBV-infected honeybees and larvae as well as the corresponding recombinant proteins. These antibodies were then used in the development of a rapid immunochromatography (IC) strip assay kit with colloidal gold coupled to pAb-rVP1 and pAb-rVP2 at the conjugate pad and mAb-rVP1-1 and mAb-rVP2-13 at the test line. One antibody pair, pAb-rVP1/mAb-VP1-1, showed positive reactivity as low as 1.38 × 103 copies, while the other pair, pAb-rVP2/mAb-VP2-13, showed positive reactivity as low as 1.38 × 104 copies. Therefore, the antibody pair pAb-rVP1/mAb-VP1-1 was selected as a final candidate for validation. To validate the detection of AcSBV, the IC strip tests were conducted with 50 positive and 50 negative samples and compared with real-time PCR tests. The results confirm that the developed IC assay is a sufficiently sensitive and specific detection method for user-friendly and rapid detection of AcSBV.
Subject(s)
Antibodies, Monoclonal , Antibodies, Viral , Bees/virology , RNA Viruses/immunology , RNA Viruses/isolation & purification , Viral Structural Proteins/immunology , Animals , Escherichia coli/genetics , Immunoassay , Mice , Mice, Inbred BALB C , Reagent Strips , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification , Sensitivity and Specificity , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purificationABSTRACT
In the face of COVID-19 pandemic caused by the newly emerged SARS-CoV-2, an inactivated, Vero cell-based, whole virion vaccine candidate has been developed and entered into phase III clinical trials within six months. Biochemical and immunogenic characterization of structural proteins and their post-translational modifications in virions, the end-products of the vaccine candidate, would be essential for the quality control and process development of vaccine products and for studying the immunogenicity and pathogenesis of SARS-CoV-2. By using a panel of rabbit antisera against virions and five structural proteins together with a convalescent serum, the spike (S) glycoprotein was shown to be N-linked glycosylated, PNGase F-sensitive, endoglycosidase H-resistant and cleaved by Furin-like proteases into S1 and S2 subunits. The full-length S and S1/S2 subunits could form homodimers/trimers. The membrane (M) protein was partially N-linked glycosylated; the accessory protein 3a existed in three different forms, indicative of cleavage and dimerization. Furthermore, analysis of the antigenicity of these proteins and their post-translationally modified forms demonstrated that S protein induced the strongest antibody response in both convalescent and immunized animal sera. Interestingly, immunization with the inactivated vaccine did not elicit antibody response against the S2 subunit, whereas strong antibody response against both S1 and S2 subunits was detected in the convalescent serum. Moreover, vaccination stimulated stronger antibody response against S multimers than did the natural infection. This study revealed that the native S glycoprotein stimulated neutralizing antibodies, while bacterially-expressed S fragments did not. The study on S modifications would facilitate design of S-based anti-SARS-CoV-2 vaccines.
Subject(s)
COVID-19 Vaccines , Protein Processing, Post-Translational , SARS-CoV-2/isolation & purification , Viral Structural Proteins , Virion , Animals , Antigens, Viral/analysis , Antigens, Viral/metabolism , COVID-19 Vaccines/chemistry , COVID-19 Vaccines/immunology , Cattle , Chlorocebus aethiops , Humans , Rabbits , SARS-CoV-2/immunology , Vaccines, Inactivated/chemistry , Vaccines, Inactivated/immunology , Vero Cells , Viral Structural Proteins/chemistry , Viral Structural Proteins/immunology , Viral Structural Proteins/isolation & purification , Virion/chemistry , Virion/immunology , Virion/isolation & purificationABSTRACT
The protruding (P) domain of the major capsid protein VP1 of norovirus (NoV) is the crucial element for immune recognition and host receptor binding. The heterologous P protein expressed by Pichia pastoris self-assembles into P particles. However, tag-free NoV protein purification schemes have rarely been reported due to the low isoelectric point of NoV proteins, which leads to highly competitive binding between the target protein and yeast host cell proteins at alkaline pH. In this study, a two-step purification scheme based on surface histidines and the charge on the NoV GII.4 strain P protein was developed. Using HisTrap and ion exchange chromatography, the P protein was directly purified, with a recovery of 28.1% and purity of 82.1%. Similarly, the NoV capsid protein VP1 was also purified using HisTrap and gel filtration chromatography based on native surface histidines and self-assembly ability, with 20% recovery and over 90% purity. Dynamic light scattering and transmission electron microscopy analyses of the purified NoV P revealed that most of these small P particles were triangle-, square- and ring-shaped, with a diameter of approximately 14 nm, and that the purified NoV VP1 self-assembles into particles with a diameter of approximately 47 nm. Both the purified NoV P and VP1 particles retained human histo-blood group antigen-binding ability, as evidenced by a saliva-binding assay.
Subject(s)
Chromatography, Ion Exchange/methods , Norovirus , Recombinant Proteins/isolation & purification , Viral Structural Proteins/isolation & purification , Chromatography, Affinity , Histidine/chemistry , Humans , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Saliva/chemistry , Saliva/metabolism , Viral Structural Proteins/chemistry , Viral Structural Proteins/metabolismABSTRACT
To explore virus-like particles formation of dengue virus serotype type 2 (DENV-2) structural proteins of, C, prM, E were expressed in silkworm larvae using recombinant Bombyx mori nucleopolyhedroviruses (BmNPV). Each recombinant BmNPV bacmid coding the 2C-prM-E polypeptide and E protein fused with the signal peptide of bombyxin from B. mori was injected into silkworm larvae. The expressed proteins were collected from hemolymph and fat body, and purified using affinity chromatography. E protein was observed at 55 kDa. The DENV virus-like particles (DENV-LPs) with a diameter approximately 35 nm was observed using transmission electron microscopy (TEM) and immunogold-labelling TEM analysis. The binding of each partially purified proteins to heparin, one of receptors for DENV was confirmed. DENV-LPs were secreted in silkworm larval hemolymph even still low amount, but the E protein and heparin binding function were confirmed.
Subject(s)
Capsid Proteins/metabolism , Dengue Virus/genetics , Nucleopolyhedroviruses/genetics , Viral Envelope Proteins/metabolism , Viral Structural Proteins/metabolism , Virion/genetics , Animals , Bombyx/growth & development , Bombyx/metabolism , Capsid Proteins/biosynthesis , Capsid Proteins/genetics , Capsid Proteins/isolation & purification , Dengue Virus/metabolism , Fat Body/metabolism , Gene Expression , Genetic Vectors , Hemolymph/metabolism , Heparin/metabolism , Larva/metabolism , Nucleopolyhedroviruses/metabolism , Protein Sorting Signals/genetics , Serogroup , Viral Envelope Proteins/biosynthesis , Viral Envelope Proteins/genetics , Viral Envelope Proteins/isolation & purification , Viral Structural Proteins/biosynthesis , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purification , Virion/ultrastructureABSTRACT
Lactobacillus plantarum is a bacterium with probiotic properties and promising applications in the food industry and agriculture. So far, bacteriophages of this bacterium have been moderately addressed. We examined the diversity of five new L. plantarum phages via whole genome shotgun sequencing and in silico protein predictions. Moreover, we looked into their phylogeny and their potential genomic similarities to other complete phage genome records through extensive nucleotide and protein comparisons. These analyses revealed a high degree of similarity among the five phages, which extended to the vast majority of predicted virion-associated proteins. Based on these, we selected one of the phages as a representative and performed transmission electron microscopy and structural protein sequencing tests. Overall, the results suggested that the five phages belong to the family Myoviridae, they have a long genome of 137,973-141,344 bp, a G/C content of 36.3-36.6% that is quite distinct from their host's, and surprisingly, 7 to 15 tRNAs. Only an average 41/174 of their predicted genes were assigned a function. The comparative analyses unraveled considerable genetic diversity for the five L. plantarum phages in this study. Hence, the new genus "Semelevirus" was proposed, comprising exclusively of the five phages. This novel lineage of Lactobacillus phages provides further insight into the genetic heterogeneity of phages infecting Lactobacillus sp. The five new Lactobacillus phages have potential value for the development of more robust starters through, for example, the selection of mutants insensitive to phage infections. The five phages could also form part of phage cocktails, which producers would apply in different stages of L. plantarum fermentations in order to create a range of organoleptic outputs.
Subject(s)
Bacteriophages/classification , Bacteriophages/isolation & purification , Lactobacillus plantarum/virology , Lactobacillus/virology , Myoviridae/classification , Myoviridae/isolation & purification , Phylogeny , Bacteriophages/genetics , Bacteriophages/ultrastructure , Base Composition , DNA Packaging , Genome, Viral , Genomics/methods , Microscopy, Electron, Transmission , Myoviridae/genetics , Myoviridae/ultrastructure , Sequence Analysis, DNA , Viral Structural Proteins/isolation & purificationABSTRACT
Inner tegument protein UL37 is conserved among all three subfamilies of herpesviruses. Studies of UL37 homologs from two alphaherpesviruses, herpes simplex virus 1 (HSV-1) and pseudorabies virus (PRV), have suggested that UL37 plays an essential albeit poorly defined role in intracellular capsid trafficking. At the same time, HSV and PRV homologs cannot be swapped, which suggests that in addition to a conserved function, UL37 homologs also have divergent virus-specific functions. Accurate dissection of UL37 functions requires detailed maps in the form of atomic-resolution structures. Previously, we reported the crystal structure of the N-terminal half of UL37 (UL37N) from PRV. Here, we report the crystal structure of HSV-1 UL37N. Comparison of the two structures reveals that UL37 homologs differ in their overall shapes, distributions of surface charges, and locations of projecting loops. In contrast, the previously identified R2 surface region is structurally conserved. We propose that within the N-terminal half of UL37, functional conservation is centered within the R2 surface region, whereas divergent structural elements pinpoint regions mediating virus-specific functions and may engage different binding partners. Together, the two structures can now serve as templates for a structure-guided exploration of both conserved and virus-specific functions of UL37.IMPORTANCE The ability to move efficiently within host cell cytoplasm is essential for replication in all viruses. It is especially important in the neuroinvasive alphaherpesviruses, such as human herpes simplex virus 1 (HSV-1), HSV-2, and veterinarian pseudorabies virus (PRV), that infect the peripheral nervous system and have to travel long distances along axons. Capsid movement in these viruses is controlled by capsid-associated tegument proteins, yet their specific roles have not yet been defined. Systematic exploration of the roles of tegument proteins in capsid trafficking requires detailed navigational charts in the form of their three-dimensional structures. Here, we determined the crystal structure of the N-terminal half of a conserved tegument protein, UL37, from HSV-1. This structure, along with our previously reported structure of the UL37 homolog from PRV, provides a much needed 3-dimensional template for the dissection of both conserved and virus-specific functions of UL37 in intracellular capsid trafficking.
Subject(s)
Herpesvirus 1, Human/chemistry , Viral Structural Proteins/chemistry , Animals , Cell Line , Chlorocebus aethiops , Crystallography, X-Ray , Models, Molecular , Protein Conformation , Vero Cells , Viral Structural Proteins/isolation & purificationABSTRACT
Since hepatitis A virus (HAV) production is time-consuming and expensive, the use of recombinant proteins may represent an alternative source of antigens for diagnostic purposes. The present study aimed to express, purify and evaluate the potential of recombinant VP1 protein (rVP1) as a marker for the diagnosis of acute HAV infection. The rVP1 was expressed and purified successfully from Escherichia coli. The purified rVP1 was used to establish an in-house enzyme-linked immunosorbent assay (ELISA-rVP1) for detection of IgM antibodies in sera from HAV-positive patients. For a cut-off point of 0.351, the sensitivity and specificity of ELISA-rVP1 were 100.0% and 95.0%, respectively. These results indicate that rVP1 may be a useful antigen for detection of IgM antibodies against HAV.
Subject(s)
Hepatitis A/diagnosis , Viral Structural Proteins/immunology , Acute Disease , Antibodies, Viral/blood , Antigens, Viral/immunology , Enzyme-Linked Immunosorbent Assay/methods , Escherichia coli/genetics , Hepatitis A/virology , Hepatitis A virus/immunology , Humans , Immunoglobulin M/blood , Recombinant Proteins/immunology , Sensitivity and Specificity , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purificationABSTRACT
Bacteriophages are the main cause of fermentation failures in dairy plants. The majority of Streptococcus thermophilus phages can be divided into either cos- or pac-type phages and are additionally characterized by examining the V2 region of their antireceptors. We screened a large number of S. thermophilus phages from the Chr. Hansen A/S collection, using PCR specific for the cos- or pac-type phages, as well as for the V2 antireceptor region. Three phages did not produce positive results with the assays. Analysis of phage morphologies indicated that two of these phages, CHPC577 and CHPC926, had shorter tails than the traditional S. thermophilus phages. The third phage, CHPC1151, had a tail size similar to those of the cos- or pac-type phages, but it displayed a different baseplate structure. Sequencing analysis revealed the genetic similarity of CHPC577 and CHPC926 with a subgroup of Lactococcus lactis P335 phages. Phage CHPC1151 was closely related to the atypical S. thermophilus phage 5093, homologous with a nondairy streptococcal prophage. By testing adsorption of the related streptococcal and lactococcal phages to the surface of S. thermophilus and L. lactis strains, we revealed the possibility of cross-interactions. Our data indicated that the use of S. thermophilus together with L. lactis, extensively applied for dairy fermentations, triggered the recombination between phages infecting different bacterial species. A notable diversity among S. thermophilus phage populations requires that a new classification of the group be proposed.IMPORTANCEStreptococcus thermophilus is a component of thermophilic starter cultures commonly used for cheese and yogurt production. Characterizing streptococcal phages, understanding their genetic relationships, and studying their interactions with various hosts are the necessary steps for preventing and controlling phage attacks that occur during dairy fermentations.
Subject(s)
Recombination, Genetic , Streptococcus Phages/classification , Streptococcus Phages/genetics , Streptococcus thermophilus/virology , Bacillus Phages , Cheese/microbiology , Cheese/virology , Cultured Milk Products/microbiology , Cultured Milk Products/virology , DNA Packaging , DNA, Viral , Fermentation , Food Microbiology , Genome, Viral , Lactococcus lactis/virology , Microscopy, Electron, Transmission , Phylogeny , Polymerase Chain Reaction/methods , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid , Species Specificity , Streptococcus Phages/isolation & purification , Streptococcus Phages/ultrastructure , Viral Structural Proteins/isolation & purification , Yogurt/microbiology , Yogurt/virologyABSTRACT
The genes for Nipah virus (NiV) proteins were amplified from viral RNA, cloned into the plasmid pTriEx-3 Hygro, expressed, and purified using immobilized metal affinity chromatography. The recombinant N, F, and G NiV proteins (rNiV-N, rNiV-F, and rNiV-G), were successfully expressed in Escherichia coli and purified with a yield of 4, 16, and 4 mg/L, respectively. All 3 recombinant viral proteins reacted with all 19 samples of NiV-positive human sera. The rNiV-N and rNiV-G proteins were the most immunogenic. The recombinant viral proteins did not react with any of the 12 NiV-negative sera. However, serum from a patient with a late-onset relapsing NiV infection complication was found to be primarily reactive to rNiV-G only. Additionally, there is a distinctive variation in the profile of antigen-reactive bands between the sample from a case of relapsing NiV encephalitis and that of acute NiV infection. The overall findings of this study suggest that the recombinant viral proteins have the potential to be developed further for use in the detection of NiV infection, and continuous biosurveillance of NiV infection in resource-limited settings.
Subject(s)
Antibodies, Viral/blood , Antigens, Viral/immunology , Nipah Virus/immunology , Recombinant Proteins/immunology , Viral Structural Proteins/immunology , Antigens, Viral/genetics , Antigens, Viral/isolation & purification , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Genetic Vectors , Humans , Plasmids , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Serum/immunology , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purificationABSTRACT
Different immunogens such as subunit, DNA or live viral-vectored vaccines against Infectious Bursal Disease virus (IBDV) have been evaluated in the last years. However, the heterologous prime-boost approach using recombinant modified vaccinia Ankara virus (rMVA), which has shown promising results in both mammals and chickens, has not been tried against this pathogen yet. IBD is a highly contagious and immunosuppressive disease of poultry that affects mainly young chicks. It is caused by IBDV, a double-stranded RNA virus carrying its main antigenic epitopes on the capsid protein VP2. Our objective was to evaluate the immune response elicited by two heterologous prime-boost schemes combining an rMVA carrying the VP2 mature gene (rVP2) and a recombinant VP2 protein produced in Nicotiana benthamiana (pVP2), and to compare them with the performance of the homologous pVP2-pVP2 scheme usually used in our laboratory. The SPF chickens immunized with the three evaluated schemes elicited significantly higher anti-VP2 antibody titers (p<0.001) and seroneutralizing titers (p<0.05) and had less T-cell infiltration (p<0.001), histological damage (p<0.001) and IBDV particles (p<0.001) in their bursae of Fabricius when compared with control groups. No significant differences were found between both heterologous schemes and the homologous one. However, the rVP2-pVP2 scheme showed significantly higher anti-VP2 antibody titers than pVP2-rVP2 and a similar tendency was found in the seroneutralization assay. Conversely, pVP2-rVP2 had the best performance when evaluated through bursal parameters despite having a less potent humoral immune response. These findings suggest that the order in which rVP2 and pVP2 are combined can influence the immune response obtained. Besides, the lack of a strong humoral immune response did not lessen the ability to protect from IBDV challenge. Therefore, further research is needed to evaluate the mechanisms by which these immunogens are working in order to define the combination that performs better against IBDV.
Subject(s)
Infectious bursal disease virus/immunology , Vaccination/methods , Viral Structural Proteins/immunology , Viral Vaccines/immunology , Animals , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Bursa of Fabricius/pathology , Chickens , Drug Carriers/administration & dosage , Infectious bursal disease virus/genetics , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification , T-Lymphocytes/immunology , Nicotiana , Vaccines, Subunit/administration & dosage , Vaccines, Subunit/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Vaccines, Synthetic/metabolism , Vaccinia virus/genetics , Viral Structural Proteins/administration & dosage , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purification , Viral Vaccines/administration & dosage , Viral Vaccines/genetics , Viral Vaccines/metabolismABSTRACT
OBJECTIVES: To improve the expression of soluble IBDV VP2 protein by using different tagged vectors in Escherichia coli. RESULTS: Fusion tags, Grifin, MBP, SUMO, thioredoxin, γ-crystallin, ArsC and PpiB, enhanced the expression and solubility of VP2 protein. The fusion proteins were purified by Ni-NTA chromatography, MBP-VP2 showed the highest purity about 90 %. After removing the MBP tag, VP2 self-assembled into virus-like particles, ~25 nm diam. Results from AGP suggested the recombinant IBDV VP2 protein identified by reference serum like IBDV. CONCLUSION: All the seven tags enhanced the expression and solubility of IBDV VP2 protein. The recombinant protein self-assembly into virus like particles and possess antigenicity as reference IBDV.
Subject(s)
Escherichia coli/genetics , Protein Engineering/methods , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Viral Structural Proteins/isolation & purification , Animals , Escherichia coli/metabolism , Gene Expression Regulation, Bacterial , Immune Sera , Immunoprecipitation , Microscopy, Electron/methods , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolism , Solubility , Viral Structural Proteins/genetics , Viral Structural Proteins/immunology , Viral Structural Proteins/metabolismABSTRACT
A novel double-stranded RNA (dsRNA) virus, designated as Botryosphaeria dothidea RNA virus 1 (BdRV1), isolated from a hypovirulent strain YZN115 of Botryosphaeria dothidea was biologically and molecularly characterized. The genome of BdRV1 comprises of five dsRNAs. Each dsRNA contains a single open reading frame. The proteins encoded by dsRNA1-4 shared significant amino acid identities of 55%, 47%, 43% and 53% with the corresponding proteins of Aspergillus fumigatus tetramycovirus-1. DsRNA1, 3, and 4 of BdRV1 encoded an RNA-dependent RNA polymerase, a viral methyltransferase, and a P-A-S-rich protein, respectively. Function of proteins encoded by the dsRNA2 and dsRNA5 were unknown. BdRV1 conferred hypovirulence for its host and could be transmitted through conidia and hyphae contact.
Subject(s)
Ascomycota/virology , Fungal Viruses/isolation & purification , RNA Viruses/isolation & purification , Ascomycota/classification , Ascomycota/isolation & purification , Ascomycota/pathogenicity , Biological Control Agents , Fungal Viruses/classification , Fungal Viruses/genetics , Genome, Viral , Peptide Mapping , Phylogeny , RNA Viruses/classification , RNA Viruses/genetics , RNA, Double-Stranded , RNA, Viral , Viral Proteins , Viral Structural Proteins/isolation & purification , VirulenceABSTRACT
Three recombinant polypeptides, VP1-His, VP1-3N-His, and 3D2-His, were produced by Escherichia coli expression system. Recombinant VP1-His, VP1-3N-His, and 3D2-His were expressed as bands with molecular weights of 32, 38, and 30 kDa, respectively. These were purified by affinity chromatography using Ni-NTA Fast-flow resin and/or ion-exchange chromatography using DEAE-Sepharose Fast-flow resin. Intraperitoneal immunizations of recombinant polypeptides successfully elicited the productions of VP1-His, VP1-3N-His, and 3D2-His specific IgG antibodies (IgG subclass distribution of IgG1>IgG2a>IgG2b>IgG3) in sera and induced the secretions of cytokines IFN-γ and IL-6 in spleen cells. Sera from recombinant VP1-His-, VP1-3N-His-, and 3D2-His-immunized mice neutralized the propagation of HAV. The highest neutralizing activity was shown in sera from recombinant VP1-3N-His-immunized mice. These results suggest that recombinant VP1-3N-His can be a useful source for developing hepatitis A virus (HAV) subunit vaccine candidates.
Subject(s)
Hepatitis A virus/immunology , Hepatitis A/prevention & control , Recombinant Proteins/immunology , Viral Structural Proteins/immunology , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , Antibodies, Viral/immunology , Capsid Proteins/genetics , Capsid Proteins/immunology , Capsid Proteins/isolation & purification , Cells, Cultured , Cloning, Molecular , Escherichia coli/genetics , Female , Hepatitis A/blood , Hepatitis A/immunology , Immunization , Immunoglobulin G/blood , Immunoglobulin G/immunology , Interferon-gamma/immunology , Interleukin-6/immunology , Mice , Mice, Inbred BALB C , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Spleen/cytology , Spleen/immunology , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purification , Viral Vaccines/genetics , Viral Vaccines/isolation & purificationABSTRACT
VP1 protein, the capsid protein of duck hepatitis A virus (DHAV), contains critical epitopes for inducing a protective immune response. Due to its low-level expression in Escherichia coli (E. coli), the function of this protein is poorly characterized. In this study, a codon-optimized VP1 gene was chemically synthesized in terms of the codon usage bias in E. coli and subcloned into pET32a (+) to increase its expression. The recombinant VP1 fusion protein was purified from inclusion body by Ni(2+) affinity chromatography His-Bind Resin and used to raise the rabbit anti-DHAV-VP1 polyclonal antibody. The expression of the codon-optimized VP1 gene in E. coli was significantly increased when compared to the wild-type VP1 gene, having an at least 17-fold increase. Western blot analysis showed that the recombinant protein was recognized by the rabbit anti-DHAV polyclonal antibody. Western blot also demonstrated that the rabbit anti-DHAV-VP1 polyclonal antibody could recognize the purified VP1 fusion protein specifically, and in the indirect immunofluorescent assays (IFA), the antibody was able to probe the VP1 protein in DHAV-1 infected cells. In conclusion, codon optimization increased dramatically DHAV VP1 expression in E. coli and the His-tagged VP1 fusion protein showed good antigenicity and immunogenicity.
Subject(s)
Antibodies, Viral/immunology , Hepatitis Virus, Duck/immunology , Viral Structural Proteins/immunology , Amino Acid Sequence , Animals , Antigens, Viral/analysis , Base Sequence , Blotting, Western , Chromatography, Affinity , Cloning, Molecular , Escherichia coli/genetics , Fluorescent Antibody Technique, Indirect , Gene Expression , Hepatitis Virus, Duck/genetics , Male , Molecular Sequence Data , Rabbits , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/isolation & purification , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purificationABSTRACT
The ability of the phage structural polypeptides to undergo post-translational modification makes the task of correlation of the primary nucleotide sequence data with the actual structural proteins of a virion extremely challenging. This study describes an alternative model approach based on two-stage chromatography for allocation of virion structural components and identification of their major polypeptides. Bacteriophage T4D, its amber mutant T4D23 (amH11) and its tail preparations were purified, concentrated and separated by ion exchange chromatograpgy based on fibrous DEAE-cellulose. The major tail fraction was then exposed to size-exclusion chromatography which enabled to separate tail components by size. This method proved itself as a highly efficient and gentle enough to save most of the biological material without changing the basic properties of the native phage. The result also shows that the accumulation of individual phage tails in the course of the amber mutant T4D23 (amH11) propagation on the permissive host Escherichia coli CR63 was resulted by changes in the conditions of reproduction. The ability of bacteriophages to form an excess of tails, capsids and other structures during reproduction on a non-traditional host provides an alternative way for obtaining highly concentrated preparations of virion components for further analysis of their major proteins and determination of the genes responsible for their synthesis.
Subject(s)
Bacteriophage T4/chemistry , Escherichia coli/virology , Viral Structural Proteins/isolation & purification , Virion/chemistry , Virus Replication/genetics , Bacteriophage T4/genetics , Capsid/chemistry , Capsid/metabolism , Chemical Fractionation/methods , Chromatography, Ion Exchange , Host Specificity , Mutation , Viral Structural Proteins/chemistry , Viral Structural Proteins/genetics , Virion/geneticsABSTRACT
Viral protein 4 (VP4) is a serine protease that catalyzes the hydrolysis of polyprotein pVP2-VP4-VP3 of infectious bursal disease virus. In this report, the recombinant VP4 with a His-tag and three mutants (VP4-S652A, VP4-K692A and VP4-S652A.K692A) were expressed in Escherichia coli. Soluble VP4 was purified using immobilized metal-ion affinity chromatography or sucrose density gradient following with gel-filtration chromatography. The purified VP4 has a tubular structure with 25-30 nm in width and â¼300 nm in length, as observed by transmission electron microscope. A similar tubular structure was also found for these three mutants. The endopeptidase activity of these VP4 tubules was characterized by fluorescence resonance energy transfer using a synthetic fluorogenic oligopeptide as a substrate. The results show that the tubule-like VP4 is a functional enzyme with K(m) of 43 ± 2 µM and k(cat) of 0.04 ± 0.01 min⻹; however, k(cat) of three mutants were significantly reduced. This is the first report to demonstrate that VP4 protein expressed in E. coli can self-assemble into functional tubule-like particles and its activity can be completely inhibited by 1 mM of Ni⺲ ions.
Subject(s)
Endopeptidases/metabolism , Infectious bursal disease virus/enzymology , Viral Structural Proteins/metabolism , Birnaviridae Infections/virology , Chromatography, Affinity , Cloning, Molecular , Endopeptidases/genetics , Endopeptidases/isolation & purification , Endopeptidases/ultrastructure , Escherichia coli/genetics , Infectious bursal disease virus/genetics , Kinetics , Nickel/metabolism , Point Mutation , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Recombinant Proteins/ultrastructure , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purification , Viral Structural Proteins/ultrastructureABSTRACT
VP22, encoded by the U(L)49 gene, is one of the most abundant proteins of the herpes simplex virus type 1 (HSV-1) tegument and has been shown to be important for virus replication and spread. However, the exact role(s) played by VP22 in the HSV-1 replication cycle have yet to be delineated. The lack of a procedure to purify full-length VP22 has limited molecular studies on VP22 function. A procedure was developed for the purification of soluble, full-length VP22 from cells infected with HSV-1. A recombinant virus encoding His-tagged VP22 was generated and found to express VP22 at levels comparable to the wild type virus upon infection of Vero cells. By experimenting with a wide variety of cell lysis buffer conditions, several buffers that promote the solubility of full-length VP22 were identified. Buffers that gave the highest levels of solubility were then used in immobilized metal ion affinity chromatography experiments to identify conditions that provided the greatest level of VP22 binding and recovery from cobalt and nickel affinity resins. Using this strategy soluble, full-length VP22 was purified from cells infected with HSV-1.
Subject(s)
Herpesvirus 1, Human/genetics , Recombinant Fusion Proteins/isolation & purification , Viral Structural Proteins/isolation & purification , Animals , Buffers , Chlorocebus aethiops , Chromatography, Affinity , Cloning, Molecular , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/chemistry , Solubility , Vero Cells , Viral Structural Proteins/biosynthesis , Viral Structural Proteins/chemistryABSTRACT
The major immunogenic proteins (E(rns), E2 and NS3) of classical swine fever virus (CSFV) (Shimen strain) were expressed in E. coli and purified by affinity chromatography. The recombinant antigens were applied to develop multiple enzyme-linked immunosorbent assays (ELISAs) for the detection of specific antibodies in pig sera. Optimum cut-off values were determined by receiver operating characteristic (ROC) analysis after testing 201 sera of vaccinated pigs and 64 negative sera of unvaccinated piglets. The multiple ELISAs were validated with 265 pig sera yielding high sensitivity and specificity in comparison with the virus neutralization results. The results demonstrated that multiple ELISAs can be a valuable tool for the detection of CSFV infection and serological surveys in CSFV-free countries or for the evaluation of the antibody responses in pigs induced by a live attenuated C-strain vaccination.
Subject(s)
Antibodies, Viral/blood , Classical Swine Fever Virus/immunology , Classical Swine Fever/diagnosis , Clinical Laboratory Techniques/methods , Veterinary Medicine/methods , Virology/methods , Animals , Antigens, Viral/genetics , Antigens, Viral/isolation & purification , Chromatography, Affinity , Enzyme-Linked Immunosorbent Assay/methods , Escherichia coli/genetics , Gene Expression , ROC Curve , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Sensitivity and Specificity , Swine , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purificationABSTRACT
Filamentous bacteriophages have been used in numerous applications for the display of antibodies and random peptide libraries. Here we describe the introduction of a 13 amino acid sequence LASIFEAQKIEWR (designated BT, which is biotinylated in vivo by E. coli) into the N termini of four of the five structural proteins of the filamentous bacteriophage fd (Proteins 3, 7, 8 and 9). The in vivo and in vitro biotinylation of the various phages were compared. The production of multifunctional phages and their application as affinity reagents are demonstrated.
Subject(s)
Bacteriophage M13/metabolism , Recombinant Fusion Proteins/metabolism , Viral Structural Proteins/metabolism , Affinity Labels/chemistry , Amino Acid Sequence , Antibodies, Viral/immunology , Antibodies, Viral/isolation & purification , Antibodies, Viral/metabolism , Bacteriophage M13/genetics , Bacteriophage M13/isolation & purification , Biotinylation , Escherichia coli/virology , Genetic Vectors , Molecular Sequence Data , Peptide Library , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Staining and Labeling , Transduction, Genetic , Viral Structural Proteins/genetics , Viral Structural Proteins/isolation & purificationABSTRACT
Although enteroviral infections occur frequently during childhood, the circulation of particular serotypes has never been studied in Greece. The objectives of the present report were molecular detection and identification of human enteroviruses in children admitted with nonspecific febrile illness or meningitis to a university hospital during a 22-month period. A one-step Real-Time RT-PCR protocol was used for rapid enterovirus detection in genetic material extracted directly from clinical samples, and a sensitive reverse transcription-semi-nested PCR targeting part of the VP1-coding region was used for genotypic identification of the different serotypes. Twenty-one enterovirus strains were detected and identified in 20 stool samples, one cerebrospinal fluid (CSF) sample, one whole blood sample and one throat swab from 21 out of 134 febrile patients (15.7%). Ten strains belonged to Human Enterovirus Species B (HEV-B) (six serotypes) and eleven to HEV-A (four serotypes). Most of the strains were closely associated with virulent strains circulating in Europe and elsewhere. Detection of the emerging pathogen enterovirus 71 for a first time in Greece was particularly important.